THORN RUN PARTNERS

Lobbying for INSTITUTE FOR GENE THERAPIES · Advocacy organization

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 17, 2025

Lobbying activity 1

Health Issues

Issues related to regulatory and reimbursement policies for innovative gene therapies.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.